Shield Therapeutics plc, announces that the following documents have now been sent to shareholders:
- Annual Report and Accounts for the year ended 31 December 2019
- Notice of Annual General Meeting (“AGM”) 2020
In accordance with AIM Rule 26, these documents are also available to view on the Company’s website www.shieldtherapeutics.com/investors/corporate-documents/ or for further details click here.
Back to news